Nolan R. Williams

Nolan R. Williams

Auto-generated profile, based on publicly available information

Nolan R. Williams

Department of Psychiatry and Behavioral Sciences, Stanford University Medical Center, Stanford, USA

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2020 in American Journal of Psychiatry
Verified
Journal Article
Closed access
ECEleanor J. Cole
Eleanor J. Cole
KSKaty H. Stimpson
Katy H. Stimpson
BBBrandon S. Bentzley
Brandon S. Bentzley
MGMerve Gulser
Merve Gulser
KCKirsten Cherian
Kirsten Cherian
NWNolan R. Williams
Nolan R. Williams

1 February 2022 in American Journal of Psychiatry
Verified
Journal Article
Closed access
ECEleanor J. Cole
Eleanor J. Cole
APAngela L. Phillips
Angela L. Phillips
BBBrandon S. Bentzley
Brandon S. Bentzley
KSKaty H. Stimpson
Katy H. Stimpson
RNRomina Nejad
Romina Nejad
NWNolan R. Williams
Nolan R. Williams

1 December 2018 in American Journal of Psychiatry
Verified
Journal Article
Closed access
NWNolan R. Williams
Nolan R. Williams
BHBoris D. Heifets
Boris D. Heifets
CBChristine Blasey
Christine Blasey
KSKeith Sudheimer
Keith Sudheimer
JPJaspreet Pannu
Jaspreet Pannu
ASAlan F. Schatzberg
Alan F. Schatzberg

5 February 2018 in Brain
Verified
Journal Article
Closed access
PDF file
NWNolan R Williams
Nolan R Williams
KSKeith D Sudheimer
Keith D Sudheimer
BBBrandon S Bentzley
Brandon S Bentzley
JPJaspreet Pannu
Jaspreet Pannu
KSKaty H Stimpson
Katy H Stimpson
ASAlan F Schatzberg
Alan F Schatzberg

29 August 2019 in Molecular Psychiatry
Verified
Journal Article
Closed access
NWNolan R. Williams
Nolan R. Williams
BHBoris D. Heifets
Boris D. Heifets
BBBrandon S. Bentzley
Brandon S. Bentzley
CBChristine Blasey
Christine Blasey
KSKeith D. Sudheimer
Keith D. Sudheimer
ASAlan F. Schatzberg
Alan F. Schatzberg

10 April 2014 in Movement Disorders Clinical Practice
Verified
Journal Article
Open access
PDF file
NWNolan R. Williams
Nolan R. Williams
KFKelly D. Foote
Kelly D. Foote
MOMichael S. Okun
Michael S. Okun
When formulating a DBS treatment plan for a patient with Parkinson's disease (PD), two critical questions should be addressed: (1) Which brain target should be chosen to optimize this patient's outcome? and (2) Should this patient's DBS operation be uni- or bilateral? Over the past two decades, two targets have emerged as leading contenders for PD DBS; the STN and the globus pallidus internus (GPi). Whereas the GPi target does have a following, most centers have uniformly employed bilateral STN DBS for all PD cases. This bilateral STN “one-size-fits-all” approach was challenged by an editorial entitled “STN versus GPi: The Rematch,” which appeared in the Archives of Neurology in 2005. Since 2005, a series of well-designed clinical trials and follow-up studies have addressed the question as to whether a more tailored approach to DBS therapy might improve overall outcomes. Such a tailored approach would include the options of targeting the GPi or choosing a unilateral operation. The results of the STN versus GPi “rematch” studies support the conclusion that bilateral STN DBS may not be the best option for every PD surgical patient. Off-period motor symptoms and tremor improve in both targets as well as with either uni- or bilateral stimulation. Advantages of the STN target include more medication reduction, less-frequent battery changes, and a more favorable economic profile. Advantages of GPi include more-robust dyskinesia suppression, easier programming, and greater flexibility in adjusting medications. In cases where unilateral stimulation is anticipated, the data favor GPi DBS. This review summarizes the accumulated evidence regarding use of bi- versus unilateral DBS and selection of STN versus GPi DBS, including definite and possible advantages of different targets and approaches. Based on this evidence, a more patient-tailored, symptom-specific approach will be proposed to optimize outcomes of PD DBS therapy. Finally, the importance of an interdisciplinary care team for screening and effective management of DBS patients will be reaffirmed. Interdisciplinary teams can facilitate the proposed patient-specific DBS treatment planning and provide a more thorough analysis of the risk-benefit ratio for each patient.